We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Siemens Healthineers - Laboratory Diagnostics

Provides advanced laboratory diagnostics solutions for the medical industry read more Featured Products: More products

Download Mobile App




Iron Supplementation Improves Hemoglobin Recovery Time Following Blood Donation

By LabMedica International staff writers
Posted on 01 Mar 2015
Print article
Siemens\' ADVIA Centaur XP Immunoassay System
The ADVIA Centaur XP Immunoassay System (Photo courtesy of Siemens Healthineers - Laboratory Diagnostics)
Among blood donors with normal hemoglobin levels, low-dose oral iron supplementation, compared with no supplementation, reduced the time to recovery of the post-donation decrease in hemoglobin.

Hemoglobin level and iron status are getting renewed attention as a donor safety issue based on increasing evidence that iron depletion is associated with fatigue, decreased exercise capacity and neurocognitive changes.

Scientists at the Institute for Transfusion Medicine (Pittsburgh, PA, USA) and their colleagues from other institutions randomly assigned 215 eligible study participants, who had not donated whole blood or red blood cells within four months to receive one tablet of ferrous gluconate daily or no iron for 24 weeks after donating a 500 mL unit of whole blood. The study was conducted at four regional blood centers in the USA.

Ferritin and soluble transferrin receptor (sTfR), were measured with the ADVIA Centaur (Siemens Healthcare Diagnostics, Deerfield, IL, USA) and a complete blood cell count (CBC) done in a pre-donation sample. Laboratory testing was performed on pre-donation EDTA blood samples collected from a sampling pouch in line with tubing used to collect the whole blood unit and then on blood samples provided on seven occasions: days 3 through 8 and at 2, 4, 8, 12, 16, and 24 weeks after donation.

The primary outcomes for the study were time to recovery of 80% of the post donation decrease in hemoglobin and recovery of ferritin level which is an indicator of the amount of total iron stored in the body. The investigators found that compared with participants who did not receive iron supplementation; those who did had shortened time to 80% hemoglobin recovery in both the low-ferritin with an average of 32 days versus 158 days, and higher-ferritin groups with an average of 31 days versus 78 days. Recovery of iron stores in all participants who received supplements took a median of 76 days; for participants not taking iron, median recovery time was longer than 168 days. Without iron supplements, 67% of participants did not recover iron stores by 168 days.

The authors concluded that although the absolute amount of hemoglobin decrease was relatively small and of marginal clinical consequence after a single blood donation, donating blood is an iterative process that leads to progressive iron loss and anemia in some frequent blood donors, so it is important that the hemoglobin decrease after blood donation be recovered before the next blood donation. Among blood donors with normal hemoglobin levels, low-dose iron supplementation, compared with no supplementation, reduced time to 80% recovery of the post donation decrease in hemoglobin concentration in donors with low ferritin (≤26 ng/mL) or higher ferritin (>26 ng/mL). The study was published on February 10, 2015, in the Journal of the American Medical Association.

Related Links:

Institute for Transfusion Medicine 
Siemens Healthcare Diagnostics 


Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Chlamydia Trachomatis Assay
Chlamydia Trachomatis IgG
New
Silver Member
Fixed Speed Tube Rocker
GTR-FS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Molecular Diagnostics

view channel
Image: The advanced molecular test is designed to improve diagnosis of a genetic form of COPD (Photo courtesy of National Jewish Health)

Groundbreaking Molecular Diagnostic Test Accurately Diagnoses Major Genetic Cause of COPD

Chronic obstructive pulmonary disease (COPD) and Alpha-1 Antitrypsin Deficiency (AATD) are both conditions that can cause breathing difficulties, but they differ in their origins and inheritance.... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.